Dual respiratory virus infections
AL Drews, RL Atmar, WP Glezen… - Clinical infectious …, 1997 - academic.oup.com
We retrospectively reviewed eight prospective epidemiological studies conducted between
1991 and 1995 for dual respiratory virus infection (DRVI) to determine the frequency, …
1991 and 1995 for dual respiratory virus infection (DRVI) to determine the frequency, …
Characteristics and outcomes of COVID-19 patients during initial peak and resurgence in the Houston metropolitan area
FS Vahidy, AL Drews, FN Masud, RL Schwartz… - Jama, 2020 - jamanetwork.com
Methods| From electronic health records, we identified patients with positive reverse
transcriptase–polymerase chain reaction (RT-PCR) nasopharyngeal swab test results for severe …
transcriptase–polymerase chain reaction (RT-PCR) nasopharyngeal swab test results for severe …
Neutralizing monoclonal antibody use and COVID-19 infection outcomes
…, D Chow, R Danan, L D'Arinzo, A Drews… - JAMA Network …, 2023 - jamanetwork.com
Importance Evidence on the effectiveness and safety of COVID-19 therapies across a diverse
population with varied risk factors is needed to inform clinical practice. Objective To assess …
population with varied risk factors is needed to inform clinical practice. Objective To assess …
Prevalence of SARS-CoV-2 infection among asymptomatic health care workers in the greater Houston, Texas, area
FS Vahidy, DW Bernard, ML Boom, AL Drews… - JAMA network …, 2020 - jamanetwork.com
Asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
continues to be a major public health concern. 1 Health care workers (HCWs) are at higher risk …
continues to be a major public health concern. 1 Health care workers (HCWs) are at higher risk …
Rapidly progressive, fatal, inhalation anthrax-like infection in a human: case report, pathogen genome sequencing, pathology, and coordinated response
…, SY Oh, G Garufi, H Maier, AL Drews… - … of pathology & …, 2011 - meridian.allenpress.com
Context.—Ten years ago a bioterrorism event involving Bacillus anthracis spores captured
the nation's interest, stimulated extensive new research on this pathogen, and heightened …
the nation's interest, stimulated extensive new research on this pathogen, and heightened …
Real-world effectiveness of COVID-19 vaccines and anti-SARS-CoV-2 monoclonal antibodies against postacute sequelae of SARS-CoV-2: analysis of a COVID-19 …
Objectives We evaluated the effectiveness of COVID-19 vaccines and monoclonal antibodies
(mAbs) against postacute sequelae of SARS-CoV-2 infection (PASC). Design and setting …
(mAbs) against postacute sequelae of SARS-CoV-2 infection (PASC). Design and setting …
[HTML][HTML] Risk factors associated with an impaired antibody response in kidney transplant recipients following 2 doses of the SARS-CoV-2 mRNA vaccine
…, A Saharia, C Mobley, H Podder, A Drews… - Transplantation …, 2022 - journals.lww.com
Background. Data about vaccine efficacy in solid organ transplant patients are limited. We
previously reported our initial observation of a 6.2% immunogenicity rate in kidney transplant …
previously reported our initial observation of a 6.2% immunogenicity rate in kidney transplant …
The influence of social determinants on receiving outpatient treatment with monoclonal antibodies, disease risk, and effectiveness for covid-19
…, D Chow, R Danan, L D'Arinzo, A Drews… - Journal of general …, 2023 - Springer
Background Limited research has studied the influence of social determinants of health (SDoH)
on the receipt, disease risk, and subsequent effectiveness of neutralizing monoclonal …
on the receipt, disease risk, and subsequent effectiveness of neutralizing monoclonal …
Real world evidence of effectiveness of covid-19 vaccines and anti SARS-CoV-2 monoclonal antibodies against post-acute sequelae of SARS-CoV-2 infection
Background We evaluated the effectiveness of COVID-19 vaccines and monoclonal
antibodies (mAb) against Post-Acute Sequelae of SARS-CoV-2 infection (PASC), an emerging …
antibodies (mAb) against Post-Acute Sequelae of SARS-CoV-2 infection (PASC), an emerging …
Houston Methodist's Mandate of Covid-19 Vaccine Boosters Among Health Care Workers: Setting Precedents During Unprecedented Times
F Vahidy, ML Boom, AL Drews, C Hackett… - … Innovations in Care …, 2022 - catalyst.nejm.org
Houston Methodist was the first health care system in the United States to mandate the
initial series of Covid-19 vaccination for its employees and employed and affiliated private-…
initial series of Covid-19 vaccination for its employees and employed and affiliated private-…